Astrana Health (ASTH) 2023年年度报告「NASDAQ」.pdf

《Astrana Health (ASTH) 2023年年度报告「NASDAQ」.pdf》由会员分享，可在线阅读，更多相关《Astrana Health (ASTH) 2023年年度报告「NASDAQ」.pdf（415页珍藏版）》请在三个皮匠报告上搜索。

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-K(Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,2023OR?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF1934

2、for the transition period from _ to _.Commission file number:001-37392Astrana Health,Inc.(Exact name of registrant as specified in its charter)Delaware95-4472349(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)1668 S.Garfield Avenue,2nd Floor,Alhambra,Ca

3、lifornia 91801(Address of principal executive offices,including zip code)Registrants telephone number,including area code:(626)282-0288Securities registered pursuant to Section 12(b)of the Act:Title of Each Class Trading Symbol Name of Each Exchange on Which RegisteredCommon Stock,$0.001 par value p

4、er share ASTH The Nasdaq Stock Market LLCSecurities registered pursuant to Section 12(g)of the Act:None(Title of class)Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No?Indicate by check mark if the registrant is not required

5、 to file reports pursuant to Section 13 or Section 15(d)of the Exchange Act.Yes?No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or forsuch shorter period that the

6、 registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No?Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405